insights_auto
Why is GNLX down 7,94%?
Dive Deeperchevron_right
GNLX:NASDAQ
Genelux Corp
2,32 $
arrow_downward
-7,94%(-0,20) 1D
2,35 $
arrow_upward
+1,29% (+0,030)bedtimeAfter hours
Closed: 14 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GNLX...
Open
2,48 $
High
2,52 $
Low
2,32 $
Mkt. cap
104,97 մլն
Avg. vol.
243,39 հզր
Volume
410,33 հզր
52-wk high
8,54 $
52-wk low
2,29 $
EPS
-0,87 $
Beta
0,59
Shares outstanding
45,24 մլն
No. of employees
26
Open
2,48 $
High
2,52 $
Low
2,32 $
Mkt. cap
104,97 մլն
Avg. vol.
243,39 հզր
Volume
410,33 հզր
52-wk high
8,54 $
52-wk low
2,29 $
EPS
-0,87 $
Beta
0,59
Shares outstanding
45,24 մլն
No. of employees
26
News stories
From web sources and news partners
GlobeNewswire
·
36 րոպե առաջ
Alignment Healthcare (NASDAQ: ALHC) Increasingly
Yahoo Finance
·
26 րոպե առաջ
Update: Nasdaq, S&P 500 Fall for Third Straight Session Following Hot CPI Data
MarketBeat
·
6 րոպե առաջ
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $28,720.00 in Stock
Seeking Alpha
·
3 ժամ առաջ
Nasdaq tumbles 2%, and these 10 stocks have fueled the selloff
Profile
Genelux Corporation is a publicly traded late clinical-stage company developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Company’s most advanced product candidate, Olvi-Vec, is a proprietary, modified strain of the vaccinia virus, a stable DNA virus with a large engineering capacity.
The core of Genelux’s discovery and development efforts revolves around the company's proprietary CHOICE™ platform from which the Company has developed an extensive library of isolated and engineered oncolytic vaccinia virus immunotherapeutic product candidates, including Olvi-Vec.
The company is currently entered its pivot Phase 3 study in Platinum resistant/refractory ovarian cancer. Trial design based on VIRO-15 Phase 2 trial which showed independent anti-tumor activity of Olvi-Vec and reversal of platinum resistance in the TME. Wikipedia
About Genelux Corp
CEO-
Employees26
Founded2001
HeadquartersWestlake Village, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websitegenelux.com